XTX Topco’s Fulcrum Therapeutics FULC Stock Holding History

XTX Topco’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$766K	Buy	209,247 +137,644	+192%	+$837K	0.01%	2044
2026 Q1	$549K	Buy	71,603 +19,801	+38%	+$184K	0.01%	1965
2025 Q4	$586K	Buy	+51,802	New	+$527K	0.02%	1462
2025 Q2	–	Sell	-49,878	Closed	-$144K	–	2634
2025 Q1	$144K	Buy	+49,878	New	+$183K	0.01%	1775
2024 Q2	–	Sell	-13,154	Closed	-$124K	–	2070
2024 Q1	$124K	Buy	+13,154	New	+$117K	0.02%	1315
2023 Q4	–	Sell	-38,918	Closed	-$173K	–	1761
2023 Q3	$173K	Sell	38,918 -44,248	-53%	-$193K	0.03%	1062
2023 Q2	$274K	Sell	83,166 -40,602	-33%	-$119K	0.05%	781
2023 Q1	$353K	Buy	123,768 +88,886	+255%	+$796K	0.07%	525
2022 Q4	$254K	Buy	+34,882	New	+$227K	0.05%	698
2022 Q3	–	Sell	-27,799	Closed	-$136K	–	1196
2022 Q2	$136K	Buy	+27,799	New	+$272K	0.06%	566

Other funds holding FULC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

XTX Topco's FULC Position: Q2 2026 in Review

XTX Topco increased its Fulcrum Therapeutics (FULC) stake by 192% in Q2 2026, buying an estimated $837K and bringing the position to 209,247 shares worth $766K. The position accounts for 0.01% of the portfolio, ranked #2044.

XTX Topco first reported a position in FULC in Q2 2022 and has held it in 10 quarters since. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

XTX Topco held 209,247 shares of Fulcrum Therapeutics worth $766K as of Q2 2026.
XTX Topco bought 137,644 Fulcrum Therapeutics shares in Q2 2026, an estimated $837K.
Fulcrum Therapeutics made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2044 holding.
XTX Topco first reported a position in Fulcrum Therapeutics in Q2 2022 and has held it in 10 quarters since.
154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.